Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38014
CAS Number:
144481-98-1
Clorhidrato de landiolol
Purity:
≥ 98 % (HPLC)
Synonym(s):
Clorhidrato de éster metílico del ácido [(4S)-2,2-dimetil-1,3-dioxolan-4-il] metil 4-[(2S)-2-hidroxi-3-[[2-[(4-morfolinilcarbonil)amino]etil]amino]propoxi]-bencenopropanoico
Documents
$200.30 /50 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
Clorhidrato de éster metílico del ácido [(4S)-2,2-dimetil-1,3-dioxolan-4-il] metil 4-[(2S)-2-hidroxi-3-[[2-[(4-morfolinilcarbonil)amino]etil]amino]propoxi]-bencenopropanoico
CAS Number
144481-98-1
Purity
≥ 98 % (HPLC)
Molecular Formula
C25H39N3O8 · HCl
Molecular Weight
546.06
MDL Number
MFCD00911043
PubChem ID
23118722
Melting Point
124 - 128 °C
Appearance
Polvo blanco a casi blanco a cristal.
Conditions
Conservar entre 2 y 8 °C.
General Information
Synonyms
Clorhidrato de éster metílico del ácido [(4S)-2,2-dimetil-1,3-dioxolan-4-il] metil 4-[(2S)-2-hidroxi-3-[[2-[(4-morfolinilcarbonil)amino]etil]amino]propoxi]-bencenopropanoico
CAS Number
144481-98-1
Purity
≥ 98 % (HPLC)
Molecular Formula
C25H39N3O8 · HCl
Molecular Weight
546.06
MDL Number
MFCD00911043
PubChem ID
23118722
Melting Point
124 - 128 °C
Appearance
Polvo blanco a casi blanco a cristal.
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Landiolol hydrochloride is widely utilized in research focused on:

  • Cardiovascular Medicine: This compound is primarily used as a rapid-acting beta-blocker to manage tachycardia and hypertension during surgical procedures, providing quick heart rate control.
  • Anesthesia: In the field of anesthesiology, landiolol is employed to stabilize heart rates in patients undergoing surgery, ensuring safer anesthesia management and reducing perioperative complications.
  • Clinical Trials: Researchers use landiolol hydrochloride in clinical studies to evaluate its efficacy and safety in various cardiac conditions, contributing to advancements in treatment protocols.
  • Pharmaceutical Development: The compound serves as a reference standard in the development of new beta-blockers, allowing for comparative studies and formulation optimization.
  • Emergency Medicine: Its rapid onset of action makes it valuable in emergency settings for acute heart rate control, providing healthcare professionals with a reliable option for urgent interventions.

Citas